Multiple Sclerosis

Latest News

Real-world Study Finds Fingolimod Leads to Better Clinical Outcomes but Higher Healthcare Costs in MS Patients
Real-world Study Finds Fingolimod Leads to Better Clinical Outcomes but Higher Healthcare Costs in MS Patients

February 9th 2024

In a retrospective study, researchers from Humana in Louisville, KY, compared clinical outcomes, time on treatment, healthcare resources utilization, and relative costs in patients with MS that were newly initiated on one of the following oral DMTs: dimethyl fumarate, fingolimod, or teriflunomide.

Study Finds Disparities in Pregnancy Care and Outcomes Among Black, Latinx, and White Women with MS
Study Finds Disparities in Pregnancy Care and Outcomes Among Black, Latinx, and White Women with MS

February 6th 2024

Kessler Foundation Researcher Receives $700K Grant to Study Barriers to Healthcare in Latinos with Multiple Sclerosis
Kessler Foundation Researcher Receives $700K Grant to Study Barriers to Healthcare in Latinos with Multiple Sclerosis

January 25th 2024

Real World Study Finds Ocrevus, Helps Highly Disabled People with MS
Real World Study Finds Ocrevus, Helps Highly Disabled People with MS

January 15th 2024

Kyverna’s CAR T-Cell Therapy Candidate Cleared for Phase 2 Trial in Progressive MS
Kyverna’s CAR T-Cell Therapy Candidate Cleared for Phase 2 Trial in Progressive MS

January 12th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.